Status:
COMPLETED
GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients
Lead Sponsor:
Bayer
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
An observational and multicenter study to assess the effectiveness and safety of Glucobay®- M under daily life treatment of type-2 diabetes patients.The study objectives are to investigate the effecti...
Eligibility Criteria
Inclusion
- Female and male patients ≥ 18 years of age with Type 2 Diabetes where investigator feels that addition of Glucobay®-M would be beneficial to patients.
- The diagnosis will be made based on the ADA criteria by the attending physician.
- Patients will be defined as included in the study if they have a documented prescription of Glucobay-M by the physician.
- Patients willing to provide signed \& dated informed consent.
- Patients willing to comply with study requirements.
Exclusion
- According to the local product information
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
9364 Patients enrolled
Trial Details
Trial ID
NCT01219582
Start Date
October 1 2010
End Date
December 1 2012
Last Update
November 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, India